1. Pink Sheet
  2. >>Product Reviews
  3. >>Post-Marketing Regulation & Studies

Drug Sponsors Are On Schedule With Most Post-Approval Studies

 
• By Brenda Sandburg

US FDA's Gottlieb touts use of real world evidence as report shows vast majority of postmarketing requirements and commitments progressing on schedule.

Report Concept. Button on Modern Computer Keyboard with Word Report on It.

Drug sponsors are scoring well on their efforts to satisfy US postmarketing requirements (PMRs) and postmarketing commitments (PMCs).

FDA's annual report on the status of the studies and clinical trials that applicants have agreed to, or are...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Post-Marketing Regulation & Studies

More from Product Reviews